Abstract
Apoptosis is now recognized as a normal feature in the development of the nervous system and may also play a role in neurodegenerative disorders, such as Alzheimers disease. Cell surface receptors, caspases, mitochondrial factors or p53 participate in the modulation and execution of cell death. Therefore, the ability to understand and manipulate the cell death machinery is an obvious goal of medical research. Potential therapeutic approaches to modulate disease by regulating apoptosis are being tested, and include the traditional use of small molecules to target specific players in the apoptosis cascade. As our understanding of apoptosis increases, further opportunities will arise for more specific therapies that will result in improved efficacy. This review focuses on molecular mechanisms of apoptosis in Alzheimers disease and highlights the potential use of small molecule modulators to treat neurodegenerative disorders.
Keywords: Alzheimer's disease, Bcl-2 family, Caspases, Death receptors, Mitochondria, p53, Small molecules, Homeostasis, Apoptosis, Reactive oxygen species, Excitotoxicity, Neurodegeneration, Programmed cell death, Cytochrome, Parkinson's disease, Neurotrophic factors, Nerve growth factor, Basic fibroblast growth factor, Brain-derived neurotrophic factor, Amyloid plaques, Neurofibrillary tangles, Amyloid b, Tau proteins, Presenilin, Autophagy, Ursodeoxycholic acid, Tauroursodeoxycholic acid, Interleukin, VX-765, IDN-6556, LB-84451, Pralnacasan, ZVAD-fmk, Ac-YVAD-cmk, Z-DEVD-fmk, ZVAD-DCB, Caspase inhibitors, Humanin, Neuroprotection
Current Pharmaceutical Design
Title: Cell Death Targets and Potential Modulators in Alzheimers Disease
Volume: 16 Issue: 25
Author(s): Rui E. Castro, Maria M.M. Santos, Paulo M.C. Gloria, Carlos J.A. Ribeiro, Duarte M.S. Ferreira, Joana M. Xavier, Rui Moreira and Cecilia M.P. Rodrigues
Affiliation:
Keywords: Alzheimer's disease, Bcl-2 family, Caspases, Death receptors, Mitochondria, p53, Small molecules, Homeostasis, Apoptosis, Reactive oxygen species, Excitotoxicity, Neurodegeneration, Programmed cell death, Cytochrome, Parkinson's disease, Neurotrophic factors, Nerve growth factor, Basic fibroblast growth factor, Brain-derived neurotrophic factor, Amyloid plaques, Neurofibrillary tangles, Amyloid b, Tau proteins, Presenilin, Autophagy, Ursodeoxycholic acid, Tauroursodeoxycholic acid, Interleukin, VX-765, IDN-6556, LB-84451, Pralnacasan, ZVAD-fmk, Ac-YVAD-cmk, Z-DEVD-fmk, ZVAD-DCB, Caspase inhibitors, Humanin, Neuroprotection
Abstract: Apoptosis is now recognized as a normal feature in the development of the nervous system and may also play a role in neurodegenerative disorders, such as Alzheimers disease. Cell surface receptors, caspases, mitochondrial factors or p53 participate in the modulation and execution of cell death. Therefore, the ability to understand and manipulate the cell death machinery is an obvious goal of medical research. Potential therapeutic approaches to modulate disease by regulating apoptosis are being tested, and include the traditional use of small molecules to target specific players in the apoptosis cascade. As our understanding of apoptosis increases, further opportunities will arise for more specific therapies that will result in improved efficacy. This review focuses on molecular mechanisms of apoptosis in Alzheimers disease and highlights the potential use of small molecule modulators to treat neurodegenerative disorders.
Export Options
About this article
Cite this article as:
E. Castro Rui, M.M. Santos Maria, M.C. Gloria Paulo, J.A. Ribeiro Carlos, M.S. Ferreira Duarte, M. Xavier Joana, Moreira Rui and M.P. Rodrigues Cecilia, Cell Death Targets and Potential Modulators in Alzheimers Disease, Current Pharmaceutical Design 2010; 16 (25) . https://dx.doi.org/10.2174/138161210793176563
DOI https://dx.doi.org/10.2174/138161210793176563 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nutraceuticals: A Comparative Analysis of Regulatory Framework in Different Countries of the World
Endocrine, Metabolic & Immune Disorders - Drug Targets The Hydrogen Peroxide and its Importance in Alzheimers and Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents Effect of Aging on Metabolic Pathways in Endothelial Progenitor Cells
Current Pharmaceutical Design Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin
Current Neurovascular Research Pivotal Role of the Interaction Between Herbal Medicines and Gut Microbiota on Disease Treatment
Current Drug Targets Editorial (Thematic Issue: Induced Cell-Based Transplantation to Therapeutically Target Spinal Cord Disorders)
Current Stem Cell Research & Therapy Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain
Current Medicinal Chemistry - Central Nervous System Agents Does Human Alpha-Synuclein Behave Like Prions?
CNS & Neurological Disorders - Drug Targets Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
Current Alzheimer Research Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
Anti-Cancer Agents in Medicinal Chemistry Design, Synthesis and Evaluation of 2,4,6-substituted Pyrimidine Derivatives as BACE-1 Inhibitor: Plausible Lead for Alzheimer’s Disease
Medicinal Chemistry Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis
Current Protein & Peptide Science Berberine: A Fluorescent Alkaloid with a Variety of Applications from Medicine to Chemistry
Mini-Reviews in Organic Chemistry Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives
Current Stem Cell Research & Therapy Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Current Medicinal Chemistry Glaucoma: Validated and Facile In Vivo Experimental Models of a Chronic Neurodegenerative Disease for Drug Development
Current Medicinal Chemistry - Central Nervous System Agents Advances in Studies on Neurodegenerative Diseases and their Treatments
Current Topics in Medicinal Chemistry Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer’s Disease: An Update
Current Medicinal Chemistry Morphological and Functional Characteristic of Senescent Cancer Cells
Current Drug Targets Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies
Current Pharmaceutical Design